{"name":"Andrew Hendifar, MD","slug":"andrew-hendifar-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Xilonix plus Onivyde and 5FU","genericName":"Xilonix plus Onivyde and 5FU","slug":"xilonix-plus-onivyde-and-5fu","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Xilonix plus Onivyde and 5FU","genericName":"Xilonix plus Onivyde and 5FU","slug":"xilonix-plus-onivyde-and-5fu","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPa0ZtS2hja0w1VkpXZ1p2Qmg3eXFtdzRaVUlrZ2NKa3lvY05RQWxLMzl4NkRqOVJzS2wtWjlsaWFhbnd3Qmo0THdPeTlMdEFHckhjeHY1TjI1ZlZ0OVNEX0JOVjQxZ1NtaWQyUDlpMkNoRzZEU2JVMFNiWFo0R0tQbE5ZR0xOdw?oc=5","date":"2026-03-04","type":"pipeline","source":"Medical Xpress","summary":"New AI tool predicts best pancreatic cancer treatment - Medical Xpress","headline":"New AI tool predicts best pancreatic cancer treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQMlY1NldZd2xQN1lDSlZROHNiWUFDZGVYWmg1VjgtWE9lNTBWRlRrTURXaldfV1hOWDBXSHlOTVl1bWxGTHV2OEgzQS1WQTZOS3dna2IyRnRhZjRfeWEzN0piczR1YlNJeUdSdzlZdlg1NUxqd19qcGxpdjlaRjNTOGI0M3phQ1owQzRSUXZ5WEYtWm1DRkxQT1pBN2tNMnZ4c1ZxckRGMXp0WnV2ZFgtM3ZFU3NzUDg5Nm9RcjZyNUZJQVVZa3VHVzJreHdFd3Fi?oc=5","date":"2026-02-25","type":"pipeline","source":"The ASCO Post","summary":"AI-Selected Biomarker Guides First-Line Treatment Selection in Advanced Pancreatic Cancer - The ASCO Post","headline":"AI-Selected Biomarker Guides First-Line Treatment Selection in Advanced Pancreatic Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE1SaGJJaU5MaEVIa1dwSVZxa2hCOW82LU5LZXo2Y0pzS245bWRhLWt1OXpNNmZsUWpvc2RGdzQxNFhmQ2ZheFVtU2N1T3dmdHBjQ1JaZGRpZl83RjJPM2JJS19tZS1uei1MMjYxbHFLdG4?oc=5","date":"2025-08-29","type":"pipeline","source":"AOL.com","summary":"Doctors Reveal the Number-1 Sign Your Pancreas Is in Trouble - AOL.com","headline":"Doctors Reveal the Number-1 Sign Your Pancreas Is in Trouble","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTFA2T0VEZ00ySWhBWUlfSEZzYV9tYXpRVTNmeld2MmFmcHJuY1BXc0VGVGFKd0p1Z2JiY2x4dm9qRDJTZWljNXR3RG9YMG8zU3VWdUJ4R09xa1pWZw?oc=5","date":"2024-09-14","type":"pipeline","source":"NEJM","summary":"Ponsegromab for the Treatment of Cancer Cachexia - NEJM","headline":"Ponsegromab for the Treatment of Cancer Cachexia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPNnh6QzVmb0MyRndvMzZiYU4tY2lPWlAxT05KemNTbHVNWjZ0OEljZXpXQ0J4LVFMWVN3NWN3VVpBVFVUQkRKZEpoMldzU2ZYQUlMaUxRVEFXRkl5VDlQZ3hVMlhUMll0R2d4MzdhbkY2eUVRZDRWRU5ZUE5mc3N6ag?oc=5","date":"2021-09-08","type":"pipeline","source":"MedPage Today","summary":"More Evidence Supports CRC Screening at Younger Ages - MedPage Today","headline":"More Evidence Supports CRC Screening at Younger Ages","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE5JblhXcURsX25lQksxRHhZUHVVei1NT2lEZHhpSS16Sl9hS3BzeTNZSjM4RHQxSkY5Mnpaa1JIUlRBc2xVeUgwNlJ6ZHdhN3prbGlWdDE3NlQ?oc=5","date":"2019-12-02","type":"pipeline","source":"ASCO Publications","summary":"Raynaud’s Phenomenon From PD-1 Immune Checkpoint Inhibition - ASCO Publications","headline":"Raynaud’s Phenomenon From PD-1 Immune Checkpoint Inhibition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFBpajUyQWl0WEh3V0dZU3A1a0V4SE5WRHc3LXdIZmVuUmFCdm1IRTZBRVFfYk8xOWJtWm1jbzFzVDNEQzdSUjNadHZXU1cyVlMwQVMyeS16RVhDc2wxeHBZNXRfTndEVGV6VHM2VXN4bXRwY3BhVnJzYlFjSQ?oc=5","date":"2014-10-13","type":"trial","source":"acsjournals.onlinelibrary.wiley.com","summary":"A phase 1B/2 study of aldoxorubicin in patients with soft tissue sarcoma - acsjournals.onlinelibrary.wiley.com","headline":"A phase 1B/2 study of aldoxorubicin in patients with soft tissue sarcoma","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}